Endothelin, the most potent vasoactive peptide known to date, has been suggested to play a potential role in the pathogenesis of open-angle glaucoma. Open-angle glaucoma is the most common optic nerve head neuropathy and is associated with a loss of retinal ganglion cells and visual field damage. Although an increased intraocular pressure is a major risk factor for glaucomatous optic neuropathy, other factors such as a reduced ocular blood flow play an important role for appearance of the disease. Thus, treatment of glaucoma is focused on lowering of intraocular pressure and preventing the occurrence or progression of glaucomatous optic neuropathy. Endothelin participates in the regulation of intraocular pressure by an effect on trabecular outflow, the main route for aqueous humour outflow from the eye. Trabecular outflow is modulated by trabecular meshwork contractility which is affected by endothelin. In addition to the effects of endothelin in the anterior part of the eye, the vasoconstrictor causes a decrease in ocular blood flow followed by pathological changes in the retina and the optic nerve head which is assumed to contribute to the degeneration of retinal ganglion cells. In sum, inhibition of endothelin signalling leads to lowering of intraocular pressure and exerts neuroprotective effects. Thus, endothelin antagonism in the eye represents a promising approach for pharmacological treatment of glaucoma.
AbbreviationsECE, endothelin-converting enzyme; ET-1, endothelin-1; ETA receptor, endothelin receptor A; ETB receptor, endothelin receptor B; FP receptor, prostaglandin F receptor; IOP, intraocular pressure; MLCK, myosin light chain kinase; MMP, matrix-metalloproteinase; OBF, ocular blood flow; PG, prostaglandin; ROCK, Rho kinase; RGC, retinal ganglion cell
IntroductionEndothelin-1 (ET-1), the most potent vasoconstrictor known to date, is expressed in many organs and tissues and has been shown to play an important role in vascular homeostasis (Yanagisawa et al., 1988) as well as in a variety of pathological processes (Levin, 1995).In the human eye endothelin is detectable in the posterior part, especially in the choroid, retinal blood vessels, retinal pigment epithelium and optic nerve (Wollensak et al., 1998;Narayan et al., 2004). The precise source of endothelin in the posterior segment of the eye remains unclear. One possible source is the retinal pigment epithelium, which secretes ET-1 towards the basolateral side, suggesting an involvement in the regulation of choroidal blood flow (Narayan et al., , 2004Dibas et al., 2005a). The ET-1 synthesis and release from optic nerve head astrocytes as seen in cultured human cells may contribute to the signal in the optic nerve (Desai et al., 2004).In the anterior part of the eye, ET-1 was found in the iris, non-pigmented ciliary epithelium, ciliary muscle, as well as in the trabecular meshwork, endothelial cells lining Schlemm's canal and corneal epithelium (Wollensak et al., 1998;Fernandez-Durango et al., 2003). Apart from its localization in ocular tissues, ...